Thompson Davis & Co’s ChemoCentryx, Inc. CCXI Stock Holding History

Thompson Davis & Co’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-625	Closed	-$9K	–	770
2018 Q1	$9K	Buy	+625	New	+$6.45K	0.02%	416
2017 Q3	–	Sell	-500	Closed	-$5K	–	1230
2017 Q2	$5K	Buy	+500	New	+$3.67K	0.01%	853

Other funds holding CCXI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Thompson Davis & Co's CCXI Position: Q2 2018 in Review

Thompson Davis & Co sold out of ChemoCentryx, Inc. (CCXI) in Q2 2018, closing a stake of 625 shares — an estimated $9K sold.

Thompson Davis & Co first reported a position in CCXI in Q2 2017 and held it in 2 quarters. The position peaked at $9K in Q1 2018. 115 funds tracked by Wall St. Rank hold CCXI as of Q2 2018.

Thompson Davis & Co reported no remaining ChemoCentryx, Inc. position as of Q2 2018 after selling out during the quarter.
Thompson Davis & Co sold 625 ChemoCentryx, Inc. shares in Q2 2018, an estimated $9K.
Thompson Davis & Co first reported a position in ChemoCentryx, Inc. in Q2 2017 and held it in 2 quarters.
Thompson Davis & Co's ChemoCentryx, Inc. position peaked at $9K in Q1 2018.
115 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2018.

Based on Thompson Davis & Co's 13F filing for Q2 2018, filed 3 Aug 2018.